Analysts’ Viewpoint on DNA and Gene Cloning Services Market Scenario
Advancement and application of novel, cutting-edge DNA cloning technology, and rise in acceptance of gene therapies are likely to propel the demand for DNA and gene cloning services globally. Surge in demand for personalized medicine, increase in the number of companies entering the market, and rise in the prevalence of chronic and hereditary diseases are major factors propelling the global market. Favorable funding environment for gene synthesis and cloning services, technological breakthroughs in cloning services, and increase in synergistic industry activities are also expected to augment the global market. Leading companies in the market are engaged in research & development of advanced and effective DNA and gene cloning services.
Gene and DNA cloning has proven to be an invaluable tool for genetics researchers in the last few years. Advancements in genetic engineering and cloning methods have led to changes in the genome sequences of microorganisms, enabling the production of chemicals with various research and therapeutic applications. Cloning can also be utilized to create gene therapies for the treatment of diseases such as genetic disorders, cancer, and AIDS.
Gene cloning could be a feasible solution to organ scarcity. It is also required for the manufacture of antimicrobials, vitamins, and hormones. Increase in application areas of DNA and gene cloning has prompted researchers to create gene libraries, which encompass a catalogue of cloned DNA. Moreover, several players are offering DNA and gene cloning services. The global DNA and gene cloning services market is highly fragmented, with the presence of numerous start-ups, mid-sized businesses, and well-established players. These players provide a range of DNA and gene cloning services using various cloning methods. Furthermore, over 35 global events have been planned to discuss recent trends in DNA and gene cloning. The DNA and gene cloning services market is expected to grow at a steady pace in the next few years, driven by a rise in the demand for gene therapies and the introduction and adoption of novel and advanced DNA cloning technologies.
The term ‘gene therapy’ refers to the process of treating a disease by altering, substituting, or enhancing a missing or deficient genetic combination that causes the illness. Gene therapy is one of the most appealing research topics in the effort to combat degenerative diseases. Rise in the prevalence of cancer and other chronic diseases globally is driving the need for gene therapy. Development of gene therapies is anticipated to lead to approvals in the next few years, which in turn is projected to augment the gene therapy market during the forecast period.
The goal of gene therapy is to treat diseases by making changes to genetic information, such as deactivating broken genes or swapping out a disease-causing gene for a healthy copy. Various disorders are being treated with gene therapy effectively. Diabetes, cancer, heart disease, and AIDS can all be cured with gene therapy. A robust product portfolio, increase in investments by major players, high prevalence of target diseases, and interest in novel & innovative therapies are fueling the gene therapy market. However, high cost of product development and stringent management practices are anticipated to restrain the global market. As per global DNA and gene cloning services market forecast, increase in investment in R&D by public and private institutions is estimated to create new opportunities in the global market during the forecast period.
DNA sequencing, a highly accurate and speedy technique used in several application areas, such as de novo arrangement, samples, and DNA resequencing, has caused a paradigm shift in proteomic and genomic studies. Consequently, a number of academic research organizations rapidly incorporated this technology into their research projects. In June 2020, the Whitehead Institute for Biomedical Research in Massachusetts, the U.S., installed the Illumina NovaSeq 6000 Sequencing System.
Development of DNA sequencing technology, its expanding usage in clinical diagnosis & drug discovery, and rise in R&D investment are driving the global DNA and gene cloning services market. Applications of DNA sequencing include forensics, reproductive health, personalized medicine, biomarkers, and diagnostics. The ability of next-generation sequencing (NGS) technology to identify and characterize clinically actionable genetic variants across a range of genes rapidly and affordably in a single test has recently been demonstrated. Furthermore, companies are offering services in sequencing. For instance, in December 2020, Eurofins Genomics launched SARS-CoV-2 NGS services that are both cost-effective and optimized, enabling for entire viral genome sequencing.
In terms of product, the custom cloning segment is expected to grow at a rapid pace during the forecast period. Custom cloning is anticipated to bring about a radical change in the biological and medical fields. Analysis of the impact of mutation on a specific gene and the production of proteins using biomedical methods are two of the primary benefits of using gene custom cloning services. Increase in penetration of synergistic services and rise in the prevalence of infectious and chronic diseases are the other factors anticipated to propel the global market during the forecast period.
Based on application, the global DNA and gene cloning services market has been segregated into DNA sequencing, mutagenesis, genotyping and others. Rapid advances in sequencing technology and bioinformatics have made it possible to identify DNA variations. These advancements also identify variants linked to an increased risk of disease. Technological advancements, expansion of partnerships and collaborations among key players, and expansion of genome mapping initiatives globally are the other factors augmenting the DNA sequencing segment. For instance, in June 2020, the Whitehead Institute for Biomedical Research in Massachusetts, the U.S., announced that it would have Illumina's NovaSeq 6000 Sequencing System installed in its center. In 2020, professors David Klenerman and Shankar Balasubramanian developed Next Generation DNA Sequencing technology.
Based on end-user, the pharmaceutical & biotechnology companies segment dominated the global market in 2021. Emergence of gene cloning services is anticipated to be benefit pharmaceutical & biotechnology companies, as these offer quick, accurate, and desired constructs, which in turn allows end-users to concentrate on other crucial research steps. Hence, rapidly evolving biomedical field is anticipated to increase DNA and gene cloning services market demand in the next five years.
North America accounted for major share of around 35.0% of the global DNA and gene cloning services market in 2021. This is ascribed to technological developments, strategic alliances, and acquisitions in the biomedical and healthcare sectors. For instance, in December 2020, Thermo Fisher increased its clinical and commercial plasmid DNA manufacturing capabilities. The opening of a new cGMP facility in Carlsbad, California, U.S. is likely to hasten the commercialization of plasmid-based drugs and vaccines. The facility would also be capable of producing large quantities of plasmid DNA, which is a critical component of drugs used in DNA treatments. This expansion builds on the company's ongoing commitment to provide cell and gene therapy services. Moreover, prioritization of the usage of DNA and gene cloning in the life science research industry, significant investments, funding, and collaborations are anticipated to drive industrial growth during the forecast period.
The DNA and gene cloning services market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to surge in the usage of DNA and gene cloning in the life science research industry, high investments, funding, and collaborations in the region.
The global DNA and gene cloning services market is consolidated, with the presence of a small number of leading players. Most of the companies are investing significantly in R&D activities, primarily to introduce advanced DNA and gene cloning services. Key players are engaging in strategic alliances to increase revenue and market share. Furthermore, diversification of product portfolios and mergers & acquisitions are the key strategies adopted by prominent players to increase footprint in the market. Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, and Twist Bioscience are the prominent players operating in the global DNA and gene cloning services market.
Each of these players has been profiled in the DNA and gene cloning services market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 2.5 Bn |
|
Market Forecast Value in 2031 |
More than US$ 9.5 Bn |
|
Growth Rate (CAGR) for 2022-2031 |
13.7% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global DNA and gene cloning services market was valued at US$ 2.5 Bn in 2021
The global DNA and gene cloning services market is projected to reach more than US$ 9.5 Bn by 2031
The global DNA and gene cloning services market is anticipated to advance at a CAGR of 13.7% from 2022 to 2031.
Rise in need for personalized medicine, increase in the number of new entrants, and surge in the prevalence of chronic and hereditary diseases
The DNA sequencing segment held more than 52% share of the global market in 2021
Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, and Twist Bioscience.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
2. Assumptions and Research Methodology
3. Executive Summary: Global DNA and Gene Cloning Services Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global DNA and Gene Cloning Services Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Top 3 players operating in the market space
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short-/ Mid-/ Long-term impact)
6. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Gene Synthesis
6.3.2. Custom Cloning
6.3.3. Sub-cloning
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. DNA Sequencing
7.3.2. Mutagenesis
7.3.3. Genotyping
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global DNA and Gene Cloning Services Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Academic & Research Institutes
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Others
9. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
10. North America DNA and Gene Cloning Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Gene Synthesis
10.2.2. Custom Cloning
10.2.3. Sub-cloning
10.2.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. DNA Sequencing
10.3.2. Mutagenesis
10.3.3. Genotyping
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Academic & Research Institutes
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe DNA and Gene Cloning Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Gene Synthesis
11.2.2. Custom Cloning
11.2.3. Sub-cloning
11.2.4. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. DNA Sequencing
11.3.2. Mutagenesis
11.3.3. Genotyping
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Academic & Research Institutes
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Latin America DNA and Gene Cloning Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Gene Synthesis
12.2.2. Custom Cloning
12.2.3. Sub-cloning
12.2.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. DNA Sequencing
12.3.2. Mutagenesis
12.3.3. Genotyping
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Academic & Research Institutes
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Middle East & Africa DNA and Gene Cloning Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Gene Synthesis
13.2.2. Custom Cloning
13.2.3. Sub-cloning
13.2.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. DNA Sequencing
13.3.2. Mutagenesis
13.3.3. Genotyping
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Academic & Research Institutes
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Aragen Life Sciences
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Bio-Techne
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Charles River Laboratories
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Curia
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Eurofins
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. GenScript
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Integrated DNA Technologies
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. MedGenome
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Sino Biological
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Company Financials
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. Syngene
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Company Financials
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
14.3.11. Twist Bioscience
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Company Financials
14.3.11.3. Growth Strategies
14.3.11.4. SWOT Analysis
List of Tables
Table 01: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 1: Global DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
Figure 2: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 3: Global DNA and Gene Cloning Services Market (US$ Mn), by Gene Synthesis, 2017–2031
Figure 4: Global DNA and Gene Cloning Services Market (US$ Mn), by Custom Cloning, 2017–2031
Figure 5: Global DNA and Gene Cloning Services Market (US$ Mn), by Sub-cloning, 2017–2031
Figure 6: Global DNA and Gene Cloning Services Market (US$ Mn), by Others, 2017–2031
Figure 7: Global DNA and Gene Cloning Services Market, by Application, 2021 and 2031
Figure 8: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 9: Global DNA and Gene Cloning Services Market (US$ Mn), by DNA Sequencing, 2017–2031
Figure 10: Global DNA and Gene Cloning Services Market (US$ Mn), by Mutagenesis, 2017–2031
Figure 11: Global DNA and Gene Cloning Services Market (US$ Mn), by Genotyping, 2017–2031
Figure 12: Global DNA and Gene Cloning Services Market (US$ Mn), by Others, 2017–2031
Figure 13: Global DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
Figure 14: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022–2031
Figure 15: Global DNA and Gene Cloning Services Market (US$ Mn), by Academic & Research Institutes
Figure 16: Global DNA and Gene Cloning Services Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 17: Global DNA and Gene Cloning Services Market (US$ Mn), by Others, 2017–2031
Figure 18: Global DNA and Gene Cloning Services Market Value Share Analysis, by Region, 2021 and 2031
Figure 19: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by Region, 2022–2031
Figure 20: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 21: North America DNA and Gene Cloning Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 22: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by Country, 2022–2031
Figure 23: North America DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
Figure 24: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 25: North America DNA and Gene Cloning Services Market, by Application, 2021 and 2031
Figure 26: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022–2031
Figure 27: North America DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
Figure 28: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022–2031
Figure 29: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: Europe DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 31: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 32: Europe DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
Figure 33: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 34: Europe DNA and Gene Cloning Services Market, by Application, 2021 and 2031
Figure 35: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022–2031
Figure 36: Europe DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
Figure 37: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022–2031
Figure 38: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Asia Pacific DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 42: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 43: Asia Pacific DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
Figure 44: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 45: Asia Pacific DNA and Gene Cloning Services Market, by Application, 2021 and 2031
Figure 46: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022–2031
Figure 47: Asia Pacific DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
Figure 48: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022–2031
Figure 49: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Latin America DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 51: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 52: Latin America DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
Figure 53: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 54: Latin America DNA and Gene Cloning Services Market, by Application, 2021 and 2031
Figure 55: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022–2031
Figure 56: Latin America DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
Figure 57: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022–2031
Figure 58: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Middle East & Africa DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 60: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 61: Middle East & Africa DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
Figure 62: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 63: Middle East & Africa DNA and Gene Cloning Services Market, by Application, 2021 and 2031
Figure 64: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022–2031
Figure 65: Middle East & Africa DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
Figure 66: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
DNA and Gene Cloning Services Market
